Potential Role of Gas Plasma in Leukemia Treatment

A unique collection of tissue samples provided by people with chronic myelogenous leukemia was the driving force behind the discovery of potentially major new therapeutic approaches to drug-resistant leukemia. This study was supported by the HCI Hematology Biobank at the Huntsman Cancer Institute (HCI) at the University of Utah.

Researchers have found that laboratory studies of specially designed gas formulations composed of charged, highly reactive molecules, called “cold atmospheric plasma” or CAP, protect healthy cells nearby. It reports that it was very effective in targeting drug-resistant leukemia cells.

Click here to read more.

    By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

    The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
    Feel free to Contact Us for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


      Avoid Gmail, Yahoo, etc. please.

      By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        The Features PDF has been emailed to you.
        Feel free to "Schedule a Demo" or "Contact Us" for any questions.

        Srikanth Adiga,
        C.E.0, OpenSpecimen
        Email: sri@krishagni.com

          By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.